Literature DB >> 12606812

The role of insulin-like growth factor 2 and its receptors in human tumors.

Kresimir Pavelic1, Damir Buković, Jasminka Pavelić.   

Abstract

Insulin-like growth factor 2 (IGF-2) is important for normal development and growth of an organism. In humans it is encoded by 11p15.5 paternally expressed imprinted gene. It binds at least two different types of receptors: IGF type 1 (IGF-1R) and IGF-2/mannose 6-phosphate receptors (IGF-2R/M6P). Ligand binding to IGF-1R provokes mitogenic and anti-apoptotic effects. IGF-2R/M6P has tumor suppressor function; it mediates IGF-2 degradation. When the IGF-2 gene/protein is overexpressed, mostly as a consequence of loss of heterozygosity resulting in paternal allele duplication (LOH) or by loss of imprinting (LOI), it is involved in the development and progression of many tumors and overgrowth syndromes by autocrine or paracrine mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12606812      PMCID: PMC2039968     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  17 in total

Review 1.  The molecular genetics of adrenocortical carcinoma.

Authors:  Ferdous M Barlaskar; Gary D Hammer
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

2.  A genetical genomics approach reveals new candidates and confirms known candidate genes for drip loss in a porcine resource population.

Authors:  Hanna Heidt; Mehmet Ulas Cinar; Muhammad Jasim Uddin; Christian Looft; Heinz Jüngst; Dawit Tesfaye; Astrid Becker; Andreas Zimmer; Siriluck Ponsuksili; Klaus Wimmers; Ernst Tholen; Karl Schellander; Christine Große-Brinkhaus
Journal:  Mamm Genome       Date:  2013-09-12       Impact factor: 2.957

3.  Genetic association study between INSULIN pathway related genes and high myopia in a Han Chinese population.

Authors:  Xiaoqi Liu; Pu Wang; Chao Qu; Hong Zheng; Bo Gong; Shi Ma; He Lin; Jing Cheng; Zhenglin Yang; Fang Lu; Yi Shi
Journal:  Mol Biol Rep       Date:  2014-09-30       Impact factor: 2.316

4.  Dietary factors, genetic and epigenetic influences in colorectal cancer.

Authors:  M L Pellegrini; P Argibay; D E Gomez
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

5.  Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.

Authors:  Doron Amit; Abraham Hochberg
Journal:  Int J Clin Exp Med       Date:  2012-08-22

6.  Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequences.

Authors:  Doron Amit; Sagi Tamir; Tatiana Birman; Ofer N Gofrit; Abraham Hochberg
Journal:  Int J Clin Exp Med       Date:  2011-04-30

7.  Variation in the IGF2 gene promoter region is associated with intramuscular fat content in porcine skeletal muscle.

Authors:  Ozlem Aslan; Ruth M Hamill; Grace Davey; Jean McBryan; Anne Maria Mullen; Marina Gispert; Torres Sweeney
Journal:  Mol Biol Rep       Date:  2011-07-21       Impact factor: 2.316

8.  Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences.

Authors:  Doron Amit; Sagi Tamir; Abraham Hochberg
Journal:  Int J Clin Exp Med       Date:  2013-01-26

9.  Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.

Authors:  Leonhard Mohr; Kakoli Banerjee; Manuela Kleinschmidt; María Matilde Bartolomé Rodríguez; Jack R Wands
Journal:  Hepatol Res       Date:  2008-07-04       Impact factor: 4.288

10.  Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.

Authors:  Qi Zhou; Ying-Qing Mao; Wei-Dong Jiang; Yun-Ru Chen; Ren-Yu Huang; Xiang-Bing Zhou; Ya-Feng Wang; Zhi Shi; Zhong-Sheng Wang; Ruo-Pan Huang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.